No Data
Earnings Preview: SSKN to Report Financial Results Post-market on November 13
Express News | Strata Skin Sciences Announces CMS Recognition of Expanded Cpt Codes for Inflammatory and Autoimmune Dermatologic Conditions With Company Anticipating Wider Excimer Adoption Ahead of 2027 Cpt Expansion
STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions With Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion
STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket
STRATA Skin Sciences Rises 25% Pre-Market — Here's Why